|
000
| 01134nam##2200253za#4500 |
|---|
| 001 | 9.572443 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624183225 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406|2000||||xxc|||||o f|0| 0 eng|d |
|---|
| 022 | |a1701-5413 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aFA1-2000/3-11E-PDF |
|---|
| 110 | 1 |aCanada. |bOffice of the Auditor General. |
|---|
| 245 | 10|aReport of the Auditor General of Canada. Chapter 26, : |h[electronic resource]|bHealth Canada - regulatory regime of biologics |
|---|
| 260 | |bOffice of the Auditor General of Canada |
|---|
| 300 | |a21p. |
|---|
| 490 | 1 |aReport of the Auditor General of Canada to the House of Commons|x1701-5413|vDecember 2000 |
|---|
| 590 | |a11-30-Supp|b2011-12-02 |
|---|
| 775 | 08|tRapport du vérificateur général du Canada. Chapitre 26, : |w(CaOODSP)9.602796 |
|---|
| 776 | 0#|tVolume 3, December 2000 |w(CaOODSP)9.615493 |
|---|
| 830 | #0|aReport of the Auditor General of Canada to the House of Commons,|x1701-5413|vDecember 2000|w(CaOODSP)9.506219 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s79 KB|uhttps://publications.gc.ca/collections/Collection/FA1-2000-3-11E.pdf|yDecember 2000 |
|---|